Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-World Analysis of the Correlation between Overall Survival and Progression-Free Survival in Advanced Pancreatic Cancer: Results of NAPOLEON-1 and 2 Studies.
Araki T, Kawahira M, Shimokawa M, Otsuka T, Hayashi K, Sonoda Y, Honda T, Nakao K, Shibuki T, Nakazawa J, Arima S, Fukahori M, Miwa K, Koga F, Ueda Y, Kubotsu Y, Makiyama A, Shimokawa H, Takeshita S, Nishikawa K, Komori A, Otsu S, Hosokawa A, Sakai T, Oda H, Arita S, Taguchi H, Tsuneyoshi K, Kawaguchi Y, Fujita T, Sakae T, Nio K, Ide Y, Ureshino N, Shirakawa T, Mizuta T, Mitsugi K. Araki T, et al. Among authors: otsu s. Oncology. 2024 Oct 19:1-11. doi: 10.1159/000542137. Online ahead of print. Oncology. 2024. PMID: 39427640
Epidemiologic and Virologic Characteristics of Influenza in Lao PDR, 2016-2023.
Wodniak N, Vilivong K, Khamphaphongphane B, Sengkeopraseuth B, Somoulay V, Chiew M, Ketmayoon P, Jiao M, Phimmasine S, Co KC, Leuangvilay P, Otsu S, Khanthamaly V, Keopaseuth P, Davis WW, Montgomery MP, Xangsayyarath P. Wodniak N, et al. Among authors: otsu s. Influenza Other Respir Viruses. 2024 Aug;18(8):e13353. doi: 10.1111/irv.13353. Influenza Other Respir Viruses. 2024. PMID: 39104091 Free PMC article.
Nanoliposomal irinotecan with fluorouracil and folinic acid, FOLFIRINOX, and S-1 as second-line treatment for unresectable pancreatic cancer after gemcitabine/nab-paclitaxel.
Shibuki T, Otsuka T, Shimokawa M, Nakazawa J, Arima S, Fukahori M, Miwa K, Okabe Y, Koga F, Ueda Y, Kubotsu Y, Makiyama A, Shimokawa H, Takeshita S, Nishikawa K, Komori A, Otsu S, Hosokawa A, Sakai T, Oda H, Kawahira M, Arita S, Honda T, Taguchi H, Tsuneyoshi K, Kawaguchi Y, Fujita T, Sakae T, Nio K, Ide Y, Ureshino N, Shirakawa T, Mizuta T, Mitsugi K. Shibuki T, et al. Among authors: otsu s. Sci Rep. 2024 Jul 23;14(1):16906. doi: 10.1038/s41598-024-65689-8. Sci Rep. 2024. PMID: 39043707 Free PMC article.
Demand for mental health support services among health professionals in Vietnam: Lesson from COVID-19 Pandemic.
Thanh NH, Manh Hung T, Ngoc TN, San BV, Hung DQ, Hung ND, Binh VD, Trung LH, Tinh LV, Nam NT, Tan PH, Khoa PTA, Thach PN, Khanh NT, Chinh CD, Trung NV, Thi TTM, Hien PB, Long TA, Thuong NV, Thanh NV, Thang TX, Truong LD, Hieu VQ, Otsu S. Thanh NH, et al. Among authors: otsu s. PLoS One. 2024 Jun 24;19(6):e0305869. doi: 10.1371/journal.pone.0305869. eCollection 2024. PLoS One. 2024. PMID: 38913676 Free PMC article.
A multicenter retrospective observational NAPOLEON2 study of nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable pancreatic cancer.
Kodama T, Imajima T, Shimokawa M, Otsuka T, Kawahira M, Nakazawa J, Hori T, Shibuki T, Arima S, Ido A, Miwa K, Okabe Y, Koga F, Ueda Y, Kubotsu Y, Shimokawa H, Takeshita S, Nishikawa K, Komori A, Otsu S, Hosokawa A, Sakai T, Sakai K, Oda H, Kawahira M, Arita S, Honda T, Taguchi H, Tsuneyoshi K, Kawaguchi Y, Fujita T, Sakae T, Shirakawa T, Mizuta T, Mitsugi K. Kodama T, et al. Among authors: otsu s. Sci Rep. 2024 May 30;14(1):12422. doi: 10.1038/s41598-024-63172-y. Sci Rep. 2024. PMID: 38816500 Free PMC article.
Author Correction: C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel.
Shirakawa T, Makiyama A, Shimokawa M, Otsuka T, Shinohara Y, Koga F, Ueda Y, Nakazawa J, Otsu S, Komori A, Arima S, Fukahori M, Taguchi H, Honda T, Shibuki T, Nio K, Ide Y, Ureshino N, Mizuta T, Mitsugi K, Akashi K, Baba E. Shirakawa T, et al. Among authors: otsu s. Sci Rep. 2024 Mar 4;14(1):5311. doi: 10.1038/s41598-024-55673-7. Sci Rep. 2024. PMID: 38438505 Free PMC article. No abstract available.
A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic Colorectal Cancer: WJOG 11018G.
Matsumoto T, Yamamoto Y, Kotaka M, Masuishi T, Tsuji Y, Shoji H, Hirata K, Tsuduki T, Makiyama A, Izawa N, Takahashi N, Tsuda M, Yasui H, Ohta T, Kito Y, Otsu S, Hironaka S, Yamazaki K, Boku N, Hyodo I, Yoshimura K, Muro K. Matsumoto T, et al. Among authors: otsu s. Target Oncol. 2024 Mar;19(2):181-190. doi: 10.1007/s11523-024-01043-2. Epub 2024 Mar 1. Target Oncol. 2024. PMID: 38427280 Free PMC article. Clinical Trial.
How Ho Chi Minh City adapted its care pathway to manage the first large-scale community transmission of COVID-19.
Khue LN, Khoa NT, Duong VA, Hien DTH, Otsu S, Quang PK, Ayana DA, Takaya S, Sobel HL, Hieu VQ. Khue LN, et al. Among authors: otsu s. Western Pac Surveill Response J. 2023 Sep 30;14(5 Spec edition):1-4. doi: 10.5365/wpsar.2023.14.5.1045. eCollection 2023. Western Pac Surveill Response J. 2023. PMID: 37969813 Free PMC article. No abstract available.
Efficacy of second-line chemotherapy after treatment with gemcitabine plus nab-paclitaxel or FOLFIRINOX in patients with metastatic pancreatic cancer.
Fukahori M, Okabe Y, Shimokawa M, Otsuka T, Koga F, Ueda Y, Nakazawa J, Komori A, Otsu S, Arima S, Makiyama A, Taguchi H, Honda T, Ushijima T, Miwa K, Shibuki T, Nio K, Ide Y, Ureshino N, Mizuta T, Mitsugi K, Shirakawa T. Fukahori M, et al. Among authors: otsu s. Sci Rep. 2023 Nov 8;13(1):19399. doi: 10.1038/s41598-023-46924-0. Sci Rep. 2023. PMID: 37938630 Free PMC article.
104 results